Literature DB >> 12505422

Activation of GABA(A) receptors by guanidinoacetate: a novel pathophysiological mechanism.

Axel Neu1, Henrike Neuhoff, Gerhard Trube, Susanne Fehr, Kurt Ullrich, Jochen Roeper, Dirk Isbrandt.   

Abstract

Guanidinoacetate methyltransferase (GAMT) deficiency is an autosomal recessively inherited disorder of creatine biosynthesis. The disease occurs in early life with developmental delay or arrest and several neurological symptoms, e.g., seizures and dyskinesia. Both the deficiency of high-energy phosphates in neurons and the neurotoxic action of the accumulated metabolite guanidinoacetate (GAA) are candidate mechanisms for the pathophysiology of this disease. To examine a potential role of GAA accumulation, we analyzed the electrophysiological responses of neurons induced by GAA application in primary culture and acute murine brain slices. GAA evoked picrotoxin- and bicuculline-sensitive GABA(A) receptor-mediated chloride currents with an EC(50) of 167 microM in cortical neurons. Pathophysiologically relevant GAA concentrations hyperpolarized globus pallidus neurons and reduced their spontaneous spike frequency with an EC(50) of 15.1 microM. Furthermore, GAA acted as a partial agonist at heterologously expressed GABA(A) but not GABA(B) receptors. The interaction of GAA with neuronal GABA(A) receptors represents a candidate mechanism explaining neurological dysfunction in GAMT deficiency.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12505422     DOI: 10.1006/nbdi.2002.0547

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  30 in total

Review 1.  Advanced physiological roles of guanidinoacetic acid.

Authors:  Sergej M Ostojic
Journal:  Eur J Nutr       Date:  2015-09-28       Impact factor: 5.614

2.  Amiloride and GMQ Allosteric Modulation of the GABA-A ρ1 Receptor: Influences of the Intersubunit Site.

Authors:  Heather D Snell; Eric B Gonzales
Journal:  J Pharmacol Exp Ther       Date:  2015-03-31       Impact factor: 4.030

3.  Guanidinoacetic acid loading affects plasma γ-aminobutyric acid in healthy men.

Authors:  Sergej M Ostojic; Marko Stojanovic
Journal:  Eur J Nutr       Date:  2015-02-14       Impact factor: 5.614

4.  A molecular characterization of the agonist binding site of a nematode cys-loop GABA receptor.

Authors:  Mark D Kaji; Ariel Kwaka; Micah K Callanan; Humza Nusrat; Jean-Paul Desaulniers; Sean G Forrester
Journal:  Br J Pharmacol       Date:  2015-05-19       Impact factor: 8.739

5.  Dietary guanidinoacetic acid does not accumulate in the brain of healthy men.

Authors:  Sergej M Ostojic; Jelena Ostojic
Journal:  Eur J Nutr       Date:  2017-12-19       Impact factor: 5.614

6.  Intrastriatal administration of guanidinoacetate inhibits Na+, K+-ATPase and creatine kinase activities in rat striatum.

Authors:  Alexandra I Zugno; Emilene B S Scherer; Patrícia F Schuck; Diogo L Oliveira; Suzana Wofchuk; Clovis M D Wannmacher; Moacir Wajner; Angela T S Wyse
Journal:  Metab Brain Dis       Date:  2006-04-27       Impact factor: 3.584

7.  Arginine derivatives of dicarboxylic acids from the parotid gland secretions of common toad Bufo bufo-New agonists of ionotropic γ-aminobutyric acid receptors.

Authors:  D S Lebedev; I A Ivanov; E V Kryukova; V G Starkov; V I Tsetlin; Yu N Utkin
Journal:  Dokl Biochem Biophys       Date:  2017-07-20       Impact factor: 0.788

8.  Guanidinoacetate decreases antioxidant defenses and total protein sulfhydryl content in striatum of rats.

Authors:  Alexandra I Zugno; Francieli M Stefanello; Emilene B S Scherer; Cristiane Mattos; Carolina D Pederzolli; Vanessa M Andrade; Clovis M D Wannmacher; Moacir Wajner; Carlos S Dutra-Filho; Angela T S Wyse
Journal:  Neurochem Res       Date:  2008-03-15       Impact factor: 3.996

9.  Guanidino acids act as rho1 GABA(C) receptor antagonists.

Authors:  Mary Chebib; Navnath Gavande; Kit Yee Wong; Anna Park; Isabella Premoli; Kenneth N Mewett; Robin D Allan; Rujee K Duke; Graham A R Johnston; Jane R Hanrahan
Journal:  Neurochem Res       Date:  2009-04-23       Impact factor: 3.996

10.  5-(N, N-Hexamethylene) amiloride is a GABA-A ρ1 receptor positive allosteric modulator.

Authors:  Heather D Snell; Eric B Gonzales
Journal:  Channels (Austin)       Date:  2016-07-01       Impact factor: 2.581

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.